Venaxis Inc news

   Watch this stock
Showing stories 1 - 10 of about 22   

Articles published

APPY 1.34 -0.01 (-0.74%)
price chart
Venaxis Announces APPY1 Test Clinical Trial Results to be Presented at ACEP14
CASTLE ROCK, Colo., Oct. 14, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1� Test, a rapid blood test for aiding in identifying children, ...
Related articles »  
Appeals court tosses fraud claim against Colorado medical-device firm
In 2010, after tests of AppyScore yielded poor results, the company's stock tanked and new executives were hired. Later, the company revamped the device, calling it Appy1, and changed the company name to Venaxis Inc. (Nasdaq: APPY).
Wall Street News: Top Gainers After-Hours Today � SCSS, TSCO, APPY, SONS ...
Venaxis Inc. (NASDAQ: APPY) traded at $1.5 up 11.1 percent during After Hours sessions on 5000 total share volume. APPY traded -15.05 percent below its fifty-day moving average and -36.19 percent below its 200-day moving average.
Court dismisses claim that AspenBio Pharma CEO intended to defraud
A lawsuit against Castle Rock-based AspenBio Pharma Inc. and current and former executives has been dismissed by the 10th U.S.
Watch List: MetLife (NYSE:MET), Twitter Inc (NYSE:TWTR), DSP Group Inc ...
Venaxis, Inc. (NASDAQ:APPY) announced that results of the company's pivotal APPY1 clinical trial will be presented on 27 October by Dr.
Investors Alert: JinkoSolar Holding Co., Ltd. (NYSE:JKS), ARM Holdings plc ...
Venaxis, Inc. (NASDAQ:APPY) announced that results of the company's pivotal APPY1 clinical trial will be presented on 27 October by Dr.
Related articles »  
Proteomics Markets for Research and IVD Applications (Mass Spectrometry ...
This report defines markets and identifies trends for proteomics applications, both in their research use and in IVD. Proteomics is the study of proteins, including the study of the structure and function of proteins.
Related articles »  
Standout performers on a year-to-date basis: United States Steel (X), Polycom ...
Polycom Inc (NASDAQ:PLCM) has booked the year to date performance of +13.40% while its market capitalization stands at $1.74 billion.
YTD Top Risers: Altria Group (MO), Archer Daniels Midland (ADM), Tyson Foods ...
Altria Group Inc (NYSE:MO) has YTD performance of +21.53%. The company has the market capitalization of $89.24 billion while its P/B ratio was 20.27.
Venaxis closes public offering of common shares